Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy.
Daniel R RichardsonXi ZhouKatherine Reeder-HayesChristopher E JensenJessica IslamKah Poh LohArjun GuptaEthan BaschAntonia V BennettJohn F P BridgesStephanie B WheelerWilliam A WoodChristopher D BaggettJennifer L LundPublished in: JAMA oncology (2024)
This retrospective study of older adults with AML using SEER-Medicare data and propensity score weighting suggests that the additional survival afforded by receiving anthracycline-based therapy was entirely offset by admission to the hospital or to nursing facilities.
Keyphrases
- acute myeloid leukemia
- healthcare
- allogeneic hematopoietic stem cell transplantation
- emergency department
- physical activity
- electronic health record
- mental health
- big data
- locally advanced
- free survival
- quality improvement
- acute care
- squamous cell carcinoma
- data analysis
- stem cells
- radiation therapy
- replacement therapy